CD18 and ICAM-1-dependent corneal neovascularization and inflammation after limbal injury.

@article{Moromizato2000CD18AI,
  title={CD18 and ICAM-1-dependent corneal neovascularization and inflammation after limbal injury.},
  author={Yasufumi Moromizato and S Stechschulte and Ken-ichi Miyamoto and Tetsuya Murata and Akitaka Tsujikawa and Antonia Maria Joussen and Anthony P. Adamis},
  journal={The American journal of pathology},
  year={2000},
  volume={157 4},
  pages={
          1277-81
        }
}
Extensive limbal injury is a leading cause of irreversible blindness. The destruction of corneal limbal stem cells often results in corneal neovascularization and an optically inferior epithelium. Previous work has shown that the neovascularization after limbal injury is vascular endothelial growth factor (VEGF)-dependent, with much of the VEGF emanating from the inflammatory cells that invade the cornea. Using a relevant mouse model of limbal injury, we examined the role of CD18 and… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 31 CITATIONS

A New Recombinant PACAP-Derived Peptide Efficiently Promotes Corneal Wound Repairing and Lacrimal Secretion.

  • Investigative ophthalmology & visual science
  • 2015
VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Corneal inflammation is inhibited by the LFA-1 antagonist, lifitegrast (SAR 1118).

  • Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
  • 2013